TSYVUNIN, V.; SHTRYGOL’, S.; HAVRYLOV, I.; SHTRYGOL’, D.; REUS, A. SGLT-2 inhibitors as potential anticonvulsants: empagliflozin, but not dapagliflozin, renders a pronounced effect and potentiates the sodium valproate activity in pentylenetetrazole-induced seizures. ScienceRise: Pharmaceutical Science, [S. l.], n. 5 (39), p. 83–90, 2022. DOI: 10.15587/2519-4852.2022.266065. Disponível em: https://journals.uran.ua/sr_pharm/article/view/266065. Acesso em: 17 jun. 2024.